LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.48 | 84.90 | 3961 | 6567 | 0.6031 | 0.8451 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.48 | 84.90 | 661 | 6567 | 0.1006 | 0.3870 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.48 | 84.90 | 4351 | 6567 | 0.6625 | 0.8729 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 57.18 | 84.90 | 290 | 6963 | 0.0416 | 0.2131 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 57.18 | 84.90 | 4117 | 6963 | 0.5912 | 0.8413 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 57.18 | 84.90 | 685 | 6963 | 0.0984 | 0.3888 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 57.18 | 84.90 | 4477 | 6963 | 0.6429 | 0.8658 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.88 | 84.90 | 322 | 7291 | 0.0442 | 0.2306 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.88 | 84.90 | 4229 | 7291 | 0.5800 | 0.8374 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.88 | 84.90 | 684 | 7291 | 0.0938 | 0.3837 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.88 | 84.90 | 4686 | 7291 | 0.6426 | 0.8670 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.59 | 84.90 | 309 | 7641 | 0.0404 | 0.2202 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.59 | 84.90 | 4417 | 7641 | 0.5780 | 0.8381 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.59 | 84.90 | 772 | 7641 | 0.1010 | 0.4050 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.59 | 84.90 | 4882 | 7641 | 0.6388 | 0.8666 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.29 | 84.90 | 339 | 7934 | 0.0427 | 0.2355 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.29 | 84.90 | 4594 | 7934 | 0.5790 | 0.8398 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.29 | 84.90 | 738 | 7934 | 0.0930 | 0.3914 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.29 | 84.90 | 5038 | 7934 | 0.6350 | 0.8659 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.99 | 84.90 | 361 | 8212 | 0.0440 | 0.2454 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.99 | 84.90 | 4746 | 8212 | 0.5779 | 0.8405 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.99 | 84.90 | 786 | 8212 | 0.0957 | 0.4013 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.99 | 84.90 | 5157 | 8212 | 0.6280 | 0.8638 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 65.70 | 84.90 | 379 | 8484 | 0.0447 | 0.2526 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 65.70 | 84.90 | 4907 | 8484 | 0.5784 | 0.8418 | MN20160318_Q02 | E22 |